# SALT for Unresectable Colorectal Liver Metastases

> **NCT06069960** · NA · NOT_YET_RECRUITING · sponsor: **RenJi Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Colon Cancer Liver Metastases

## Interventions

- **PROCEDURE:** sequential adult left lateral lobe liver transplantation (SALT)

## Key facts

- **NCT ID:** NCT06069960
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10-20
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069960, "SALT for Unresectable Colorectal Liver Metastases". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06069960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
